|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/52 | (2006.01) |
| A61K 45/06 | (2013.01) | ||
| C07D 487/04 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 3484477 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17828498.0 |
| Europos patento paraiškos padavimo data | 2017-07-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-05-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-09-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/042011 |
| Data | 2017-07-13 |
| (87) | Numeris | WO 2018/013862 |
| Data | 2018-01-18 |
| (30) | Numeris | Data | Šalis |
| 201662362369 P | 2016-07-14 | US |
| (72) |
NIESMAN, Michael , US
ZHANG, Kai , US
|
| (73) |
Mingsight Pharmaceuticals, Inc. ,
P.O. Box 261208, San Diego, CA 92196,
US
|
| (54) | TREATMENT OF CANCER |
| TREATMENT OF CANCER |